维普期刊资源整合服务平台（V6.5）

126篇 您的检索式：作者名="Regan MM"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Lysine requirements of healthy adult Indian subjects receiving long-term feeding measured with a 24-h indicator amino acid oxidation and balance technique 显示文摘	Kurpad AV Regan MM Raj T	2002	Am J Clin Nutr2002，76，2：	1
2	Predictive value of tumor Ki-67 expression in two randomized tri- als of adjuvant chemoendocrine therapy for node-nega tive breast cancer显示文摘	Viale G Regan MM Mastropasqua MG	2008	J Nat1 Cancer Inst2008，100，3：	1
3	Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 random- ised clinical trial at 8 1 years median tollow-up 显示文摘	Regan MM Neven P Giobbie-Hurder A	2011	Lancet Oncol2011，12，12：	1
4	Random- ized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma 显示文摘	McDermott DF Regan MM Clark JI	2005	J Clin Oncol2005，23，1：	1
5	Analyses adjusting for selective crossover show improved overall survival with adjuvant \|etrozole compared with tamoxifen in the BIG 1-98 study 显示文摘	Colteoni M Giobbie-Hurder A Regan MM	2011	J Clin Oncol2011，29，9：	1
6	The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection显示文摘	Ung JO San Francisco IF Regan MM	2003	J Urol2003，169，1：	1
7	Randomized phase 11I trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma显示文摘	McDermott DF Regan MM Clark JI	2005	J Clin Oncol2005，23，1：	1
8	A randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinomar 显示文摘	McDermott DF Regan MM Clark JI	2005	J Clin Oncol2005，23，1：	1
9	Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole 显示文摘	Viale G Giobbie-Hurder A Regan MM	2008	J Clin Oncol2008，26，34：	1
10	Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth fac- tor-targeted therapy 显示文摘	Choueiri TK Regan MM Rosenberg JE	2010	BJU Int2010，106，6：	1
11	Predictive value of tumor Ki -67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer 显示文摘	Viale G Regan MM Mastropasqua MG	2008	J Natl Cancer Inst2008，100，3：	1
12	Echocardiographic predictors of left ventricular outflow tract obstruction and systolic anterior motion of the mitral valve after mitral valve reconstruction for myxomatous valve disease显示文摘	Maslow AD Regan MM Haering JM	1999	J Am Coll Cardiol1999，34，7：	1
13	Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate显示文摘	Tay MH Kanfman DS Regan MM	2004	Ann Oncol2004，15，3：	1
14	Prediction of erectile function following treatment for prostate cancer 显示文摘	Alemozaffar M Regan MM Cooperberg MR	2011	JAMA2011，306，11：	1
15	Retrospective analysis of the safety and efficacy of interlcukin-2 after prior VEGF-targeted therapy in patients with advanced renal cell carcinoma显示文摘	Cho DC Puzanov I Regan MM	2009	J Im- munother2009，32，2：	1
16	Interpreting Breast In- ternational Group (BIG) 1-98 : a randomized, double-blind, phase 111trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer 显示文摘	Regan MM Price KN Giobbie-Hurder A	2011	Breast Cancer Res2011，13，3：	1
17	Randomized phase Ⅲ trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma显示文摘	McDermott DF Regan MM Clark JI		0，，01：	1
18	Evidence for cardiomyopathy in familial diabetes mellitus显示文摘	Regan TJ Lyons MM Ahmed SS	1977	J Clin Invest1977，60，：	1
19	Prog- nostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endo- crine-responsive breast cancer: results from Breast In- ternational Group Trial 1-98 comparing adjuvant tamoxifen with letrozole显示文摘	Viale G Giobbie-Hurder A Regan MM	2008	J Clin Oncol2008，26，34：	1
20	Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer:BIG 1-98显示文摘	Viale G Regan MM Maiorano E	2007	J Clin Oncol2007，25，25：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示